by molly | Mar 24, 2026 | Media
RxCelerate launches RxPlorer™: A new protein metastate discovery platform, unlocking new possibilities for screening against undruggable targets Cutting-edge platform technology leveraging advanced molecular dynamics to uncover protein metastates and reveal novel...
by molly | Nov 19, 2025 | Media
RxCelerate and Constructive Bio Announce Partnership to Advance Next-Generation Therapeutics Cambridge, UK, 19th November 2025, 9am GMT Combining Constructive Bio’s pioneering programmable biology platform with RxCelerate’s expert drug design and development...
by molly | Apr 29, 2025 | Media
RxCelerate Assembles a World-Class Scientific Advisory Board for its Biologics Discovery Unit Cambridge, UK & Cambridge, MA, Tuesday 29 April 2025, 1pm BST RxCelerate, the Cambridge-based out-sourced drug discovery and development leader, has unveiled a...
by molly | Apr 1, 2025 | Media
RxCelerate Wins Best Performing R&D Services Provider Award Cambridge, UK, 1st April 2025, 1pm BST We are delighted to share that RxCelerate was named Best Performing R&D Services Provider Company of the Year at last night’s One Nucleus Annual Awards...
by molly | Oct 15, 2024 | Media
RxCelerate & Babraham Research Campus host panel on “Prioritising mental health in the workplace” Cambridge, UK 15th October 2024, 9AM GMT World Mental Health Day was on the 10th of October, and it is a day for mental health education, awareness and...
by hafeez | Sep 18, 2024 | Media
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease Cambridge, UK Wednesday 18th September 2024, 9AM GMT Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke...
